Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

Changes in measurement of Haemophilus influenzae serotype b (Hib) vaccination coverage --- National Immunization Survey, United States, 2009.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2010 Aug 27;59(33):1069-72.

2.

Updated recommendations for use of Haemophilus influenzae type b (Hib) vaccine: reinstatement of the booster dose at ages 12-15 months.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2009 Jun 26;58(24):673-4.

3.

Invasive Haemophilus influenzae Type B disease in five young children--Minnesota, 2008.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2009 Jan 30;58(3):58-60.

4.

Licensure of a Haemophilus influenzae type b (Hib) vaccine (Hiberix) and updated recommendations for use of Hib vaccine.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2009 Sep 18;58(36):1008-9.

5.

Effects of a nationwide Hib vaccine shortage on vaccination coverage in the United States.

Santibanez TA, Shefer A, Briere EC, Cohn AC, Groom AV.

Vaccine. 2012 Jan 20;30(5):941-7. doi: 10.1016/j.vaccine.2011.11.075. Epub 2011 Nov 30.

PMID:
22137879
6.

Continued shortage of Haemophilus influenzae Type b (Hib) conjugate vaccines and potential implications for Hib surveillance--United States, 2008.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2008 Nov 21;57(46):1252-5.

7.

Invasive disease due to Haemophilus influenzae serotype b ten years after routine vaccination, South Africa, 2003-2009.

von Gottberg A, Cohen C, Whitelaw A, Chhagan M, Flannery B, Cohen AL, de Gouveia L, Plessis Md, Madhi SA, Klugman KP; Group for Enteric, Respiratory, Meningeal Disease Surveillance in South Africa (GERMS-SA)..

Vaccine. 2012 Jan 11;30(3):565-71. doi: 10.1016/j.vaccine.2011.11.066. Epub 2011 Nov 26.

PMID:
22119925
8.

National, state, and local area vaccination coverage among children aged 19-35 months --- United States, 2009.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2010 Sep 17;59(36):1171-7.

9.

National, state, and local area vaccination coverage among children aged 19-35 months - United States, 2008.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2009 Aug 28;58(33):921-6.

10.

Lessons learned from the 2007 to 2009 Haemophilus influenzae type B vaccine shortage: implications for future vaccine shortages and public health preparedness.

Chamberlain AT, Wells K, Seib K, Kudis A, Hannan C, Orenstein WA, Whitney EA, Hinman AR, Buehler JW, Omer SB, Berkelman RL.

J Public Health Manag Pract. 2012 May-Jun;18(3):E9-E16. doi: 10.1097/PHH.0b013e31821dce27.

PMID:
22473128
11.

Haemophilus influenzae type b disease: impact and effectiveness of diphtheria-tetanus toxoids-acellular pertussis (-inactivated poliovirus)/H. influenzae type b combination vaccines.

Schmitt HJ, von Kries R, Hassenpflug B, Hermann M, Siedler A, Niessing W, Clemens R, Weil J.

Pediatr Infect Dis J. 2001 Aug;20(8):767-74.

PMID:
11734739
13.

Up-to-date Haemophilus influenzae type b vaccination coverage during a vaccine shortage.

White KE, Pabst LJ, Cullen KA.

Pediatrics. 2011 Mar;127(3):e707-12. doi: 10.1542/peds.2010-2129. Epub 2011 Feb 21.

PMID:
21339271
14.

National, state, and local area vaccination coverage among children aged 19-35 months--United States, 2006.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2007 Aug 31;56(34):880-5.

15.

Four and one-half-year follow-up of the effectiveness of diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b and diphtheria-tetanus toxoids-acellular pertussis-inactivated poliovirus/H. influenzae type b combination vaccines in Germany.

Kalies H, Verstraeten T, Grote V, Meyer N, Siedler A, Schmitt HJ, Breuer T, Moulton LH, von Kries R; Erhebungseinheit für seltene pädiatrische Erkrankungen in Deutschland Study Group..

Pediatr Infect Dis J. 2004 Oct;23(10):944-50.

PMID:
15602195
16.

A new DTPw-HB/Hib combination vaccine for primary and booster vaccination of infants in Latin America.

Tregnaghi M, López P, Rocha C, Rivera L, David MP, Rüttimann R, Schuerman L.

Rev Panam Salud Publica. 2006 Mar;19(3):179-88.

PMID:
16640847
17.

Haemophilus influenzae Type b disease among Amish children in Pennsylvania: reasons for persistent disease.

Fry AM, Lurie P, Gidley M, Schmink S, Lingappa J, Fischer M, Rosenstein NE.

Pediatrics. 2001 Oct;108(4):E60.

PMID:
11581468
18.

NTAGI subcommittee recommendations on Haemophilus influenzae type B (Hib) vaccine introduction in India.

Subcommittee on Introduction of Hib Vaccine in Universal Immunization Program, National Technical Advisory Group on Immunization, India..

Indian Pediatr. 2009 Nov;46(11):945-54.

19.

Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.

Lehmann D, Kakazo M, Saleu G, Taime J, Javati A, Namuigi P, Alpers MP, Wegmüller B, Zellmeyer M, Fürer E, Que JU, Herzog C.

P N G Med J. 2001 Mar-Jun;44(1-2):6-16.

PMID:
12418673
20.

County-level trends in vaccination coverage among children aged 19-35 months - United States, 1995-2008.

Smith PJ, Singleton JA; National Center for Immunization and Respiratory Diseases.; Centers for Disease Control and Prevention (CDC)..

MMWR Surveill Summ. 2011 Apr 29;60(4):1-86.

Supplemental Content

Support Center